Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Branson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|September 3, 2002
Estimating a treatment effect in survival studies in which patients switch treatmentMichael Branson, John Whitehead
Statistics in Medicine|October 1, 2003
A score test for binary data with patient non-complianceMichael Branson, John Whitehead
Journal of Biopharmaceutical Statistics|December 14, 2004
Modeling missingness for time-to-event data: a case study in osteoporosisBeat Neuenschwander, Michael Branson
Statistics in Medicine|January 19, 2010
A combined score test for binary and ordinal endpoints from clinical trialsJohn Whitehead, Michael Branson, Susan Todd
Statistics in Medicine|March 18, 2008
Critical aspects of the Bayesian approach to phase I cancer trialsBeat Neuenschwander, Michael Branson, Thomas Gsponer
Statistics in Medicine|September 8, 2009
A note on the power priorBeat Neuenschwander, Michael Branson, David J Spiegelhalter
Journal of Biopharmaceutical Statistics|April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariatesStuart Bailey, Beat Neuenschwander, Glen Laird, et al.
Clinical Trials (London, England)|February 17, 2010
Summarizing historical information on controls in clinical trialsBeat Neuenschwander, Gorana Capkun-Niggli, Michael Branson, et al.
Statistics in Medicine|February 26, 2011
A proof of concept phase II non-inferiority criterionBeat Neuenschwander, Nicolas Rouyrre, Norbert Hollaender, et al.
Clinical Trials (London, England)|February 2, 2011
Bayesian models for subgroup analysis in clinical trialsHayley E Jones, David I Ohlssen, Beat Neuenschwander, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|September 3, 2002
Estimating a treatment effect in survival studies in which patients switch treatmentMichael Branson, John Whitehead
Statistics in Medicine|October 1, 2003
A score test for binary data with patient non-complianceMichael Branson, John Whitehead
Journal of Biopharmaceutical Statistics|December 14, 2004
Modeling missingness for time-to-event data: a case study in osteoporosisBeat Neuenschwander, Michael Branson
Statistics in Medicine|January 19, 2010
A combined score test for binary and ordinal endpoints from clinical trialsJohn Whitehead, Michael Branson, Susan Todd
Statistics in Medicine|March 18, 2008
Critical aspects of the Bayesian approach to phase I cancer trialsBeat Neuenschwander, Michael Branson, Thomas Gsponer
Statistics in Medicine|September 8, 2009
A note on the power priorBeat Neuenschwander, Michael Branson, David J Spiegelhalter
Journal of Biopharmaceutical Statistics|April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariatesStuart Bailey, Beat Neuenschwander, Glen Laird, et al.
Clinical Trials (London, England)|February 17, 2010
Summarizing historical information on controls in clinical trialsBeat Neuenschwander, Gorana Capkun-Niggli, Michael Branson, et al.
Statistics in Medicine|February 26, 2011
A proof of concept phase II non-inferiority criterionBeat Neuenschwander, Nicolas Rouyrre, Norbert Hollaender, et al.
Clinical Trials (London, England)|February 2, 2011
Bayesian models for subgroup analysis in clinical trialsHayley E Jones, David I Ohlssen, Beat Neuenschwander, et al.
Pageof 2